| Current Price | $133.20 | Mkt Cap | $16.6B |
|---|---|---|---|
| Open | $133.81 | P/E Ratio | 8.00 |
| Prev. Close | $135.08 | Div. (Yield) | $2.48 (1.8%) |
| Daily Range | $131.46 - $134.37 | Volume | 918,303 |
| 52-Wk Range | $113.36 - $174.16 | Avg. Daily Vol. | 1,235,290 |
A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.
| Current Price | $133.20 | Mkt Cap | $16.6B |
|---|---|---|---|
| Open | $133.81 | P/E Ratio | 8.00 |
| Prev. Close | $135.08 | Div. (Yield) | $2.48 (1.8%) |
| Daily Range | $131.46 - $134.37 | Volume | 918,303 |
| 52-Wk Range | $113.36 - $174.16 | Avg. Daily Vol. | 1,235,290 |
The best Bull and Bear pitches based on recency and number of recommendations.
Low p/e p/b and p/s with solid profits dividends and return of equity. It has quite a bit of debt (debt to equity of .8), but still has decent cash flow. No real growth.
Near-term reimbursement decreases from ACA and regular decreases in Medicare fee schedule. Theranos accepts 50% of the Medicare rate, and process is much more patient friendly; this is the real threat to DGX and LH.
Read the most recent pitches from players about DGX.
Recs
TMFjimhalley
(< 20)
Submitted: 8/4/2021 12:22:52 PM :
Start Price:
$145.89
NYSE:DGX Score:
-7.86
The company's size and diversity gives it economies of scale. It did well with COVID testing, but will do even better once regular medical tests get back to normal levels.
Recs
TMFkodyk123
(55.47)
Submitted: 7/22/2021 1:56:51 PM :
Start Price:
$136.35
NYSE:DGX Score:
-2.40
Quest Diagnostics benefits from solid operating fundamentals, a robust balance sheet, and shares trade at a double-digit discount to fair value, which should lead to high-single digit to low-double digit annual total returns over the next 5 years.
Recs
NoOracleHere
(< 20)
Submitted: 6/17/2021 11:17:02 AM :
Start Price:
$125.33
NYSE:DGX Score:
+3.03
Aging population, ACA
Find the members with the highest scoring picks in DGX.
amicidelbosco (34.49) Score: +195.84
The Score Leader is the player with the highest score across all their picks in DGX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| amicidelbosco | 34.49 | 7/9/2009 |
|
3W | $44.80 | +197.83% | +393.67% | +195.84 | 0 Comment | |
| rtaliano | < 20 | 12/23/2009 |
|
1Y | $49.73 | +168.29% | +289.54% | +121.26 | 1 Comment | |
| PurePwnage | 98.59 | 11/27/2009 |
|
5Y | $47.08 | +183.39% | +302.48% | +119.09 | 0 Comment | |
| DiamondDawg | 90.41 | 11/25/2009 |
|
5Y | $47.82 | +179.02% | +292.45% | +113.43 | 0 Comment | |
| charmatica | 59.13 |
|
|
3Y | $36.72 | +263.29% | +362.48% | +99.19 | 0 Comment | |
| Dividends500 | 85.92 |
|
|
5Y | $43.54 | +206.43% | +142.79% | +63.65 | 1 Comment | |
| EliteMerchant | 92.11 | 9/29/2008 |
|
5Y | $40.11 | +232.62% | +296.09% | +63.48 | 0 Comment | |
| line70day | < 20 | 2/28/2014 |
|
1Y | $45.32 | +194.37% | +134.51% | +59.86 | 1 Comment | |
| Zergum | < 20 | 3/3/2014 |
|
5Y | $45.16 | +195.43% | +136.23% | +59.20 | 0 Comment | |
| 345adf | 37.03 | 3/3/2014 |
|
5Y | $45.16 | +195.43% | +136.23% | +59.20 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
